Study of a mouth care plan for dry mouth in diabetes
Part of Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests a special mouth care plan to help people with diabetes who have dry mouth. The goal is to see if it improves comfort and mouth health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a single stone in the kidney's main drainage area (renal pelvis).
- You are under 18 years old.
- You do not have any other urinary tract problems (present from birth or later).
- You do not have any lung disease (like chronic lung disease or pleural effusion).
- You do not have multiple kidney stones, stones in the kidney's cuplike structures (calyces), or a blockage where the kidney meets the ureter.
- You do not have a kidney located in an unusual position (pelvic kidney).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how people with diabetic kidney disease engage with their care. It may help find ways to better support patients, though it does not test a new treatment.
This study is for people with certain rare kidney conditions that can cause kidney stones. It aims to learn how these conditions behave over time and may help improve future care.
This trial studies whether some people can avoid getting a ureteral stent after ureteroscopy and lithotripsy for a kidney stone. It may help reduce stent-related discomfort while still keeping outcomes safe for the stone problem.
This trial is testing a new type of temporary tube (stent) that dissolves on its own after being placed in the ureter following kidney stone surgery. It looks at how safe and well the stent works to keep the ureter open while healing.
This study looks at the amount of tiny plastic particles (microplastics) in urine from people with kidney or ureter stones. The goal is to see if these particles are linked to stone formation, which could help prevent stones in the future.
This trial tests if an oral medication that absorbs toxins plus probiotics can reduce inflammation and slow kidney damage in people with diabetes-related kidney disease (DKD). It may help those with mild to severe kidney function loss.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.